Consultations

Latest consultations

• 09 Feb 2010 | Public consultation (MLX 367): Proposals for amendments to the Prescription Only Medicines (Human Use) Order 1997 (the POM Order)
  

  This consultation seeks views on whether to amend the list of Prescription Only Medicines which can be administered parenterally by anyone for the purpose of saving life in an emergency under Article 7 of the POM Order.

• 01 Feb 2010 | Public consultation (MLX 366): Intention to amend the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008 (SI 2008/1692)
  

  MLX 366 seeks your views on how current professional guidance can be expanded to provide additional support for community pharmacists following forthcoming legislative changes and also seeks views on any impact on businesses or equality issues.

• 01 Feb 2010 | Public consultation (MLX 364): The regulation of nicotine containing products
  

  MLX 364 seeks your views on whether to bring all nicotine containing products (NCPs), with the exception of tobacco and tobacco products, within the medicines licensing regime.

• 18 Dec 2009 | Public consultation (MLX 365): Measures to strengthen the medicines’ supply chain and reduce the risk from counterfeit medicines
  

  MLX 365 seeks your views on specific proposals designed to strengthen the medicines supply chain in the UK. It follows and builds on responses to ideas set out in an earlier consultation.

• 19 Oct 2009 | Public consultation (MLX 363): MHRA regulatory fees for medicines - proposals for 1 April 2010
  

  MLX 363 seeks your views on proposals to change the levels of fees charged by the MHRA for the regulation of medicines, including herbal and homoeopathic medicines, and blood establishments and blood banks.

• 19 Oct 2009 | Public consultation (RCX/004/002/042): MHRA regulatory fees for medical devices - proposals for 1 April 2010
  

  This consultation seeks your views on proposals to change the levels of fees charged by the MHRA for our medical device regulatory activities covering notified bodies (NBs) and conformity assessment bodies (CABs).

• 10 Sep 2009 | Draft guidance for comment on the UK's arrangements under the hospital exemption scheme for advanced therapy medicinal products. Deadline for comments is Friday 18 September
  

  This draft guidance has been developed on the proposed UK exemption scheme for advanced therapy medicinal products (ATMPs). A quick reminder that the deadline for comments is Friday 18 September.

• 28 Aug 2009 | Public consultation (MLX 362): Sale, supply and administration of medicines by dental hygienists and dental therapists under a Patient Group Direction
  

  MLX 362 seeks your views on proposals to amend medicines legislation to enable dental hygienists and dental therapists to sell, supply and administer medicines under a Patient Group Direction (PGD).

• 27 Aug 2009 | Public consultation (ARM 64): Request to reclassify Galpharm Non-drowsy Hayfever and Allergy Relief Tablets from pharmacy (P) to general sale list (GSL)
  

  Consultation ARM 64 seeks your views on the reclassification for a pack size of 14 loratadine 10mg tablets (Galpharm Non-drowsy Hayfever and Allergy Relief Tablets) from P to GSL.

• 14 Aug 2009 | Public consultation (MLX 358): The European Commission proposals on information to patients for prescription medicines
  

  MLX 358 sought your views on a European Commission proposal that would allow the pharmaceutical industry to provide information to the public on prescription only medicines, as advertising of these medicines to the public is not allowed.